Jessica Nance, MD, MS, discusses maximizing gene therapy efficiency by selecting vectors for gene size, tissue targeting, and low exposure, and focusing on precise promoters for expression. This is a ...
For biopharmaceutical companies, gene therapies are an economic challenge. They are expensive to make yet the diseases the treat are rare, so manufacturers tend to charge a lot for them to generate ...
LONDON, Feb. 4, 2026 /PRNewswire/ -- VIPRE Security Group, a global leader and award-winning cybersecurity, privacy, and data protection company, releases its Q4 2025 Email Threat Trends Report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results